Treatment of Homozygous Type II Antithrombin Heparin-Binding Site Deficiency in Pregnancy
Pregnancy is associated with an increased risk of venous thromboembolism (VTE). Previous VTE and severe thrombophilia are important risk factors. Our case was a 36-year-old woman, gravida 6, para 0, with antithrombin (AT) deficiency caused by a homozygous mutation in the heparin-binding site (HBS)....
Main Authors: | Hilde Fiskvik, Anne F. Jacobsen, Nina Iversen, Carola E. Henriksson, Eva-Marie Jacobsen |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | Case Reports in Obstetrics and Gynecology |
Online Access: | http://dx.doi.org/10.1155/2021/4393821 |
Similar Items
-
Heparin binding and activation of antithrombin
by: Christey, Peter B.
Published: (1989) -
Heparanase Activates Antithrombin through the Binding to Its Heparin Binding Site.
by: Nataliya Bohdan, et al.
Published: (2016-01-01) -
Modulation of antithrombin by heparin
by: Fitton, Hazel Louise
Published: (1998) -
On the specificity of heparin/heparan sulfate binding to proteins. Anion-binding sites on antithrombin and thrombin are fundamentally different.
by: Philip D Mosier, et al.
Published: (2012-01-01) -
Antithrombin structures and the heparin pentasaccharide
by: Jin, L.
Published: (1998)